Skip to main content
Lukman Tijani, MD, Oncology, Lubbock, TX

Lukman A. Tijani MD


Assistant Professor, Internal Medicine, Texas Tech University Health

Join to view full profile
  • 602 Indiana AveLubbock, TX 79415

  • Phone+1 806-775-8600

  • Fax+1 806-775-8602

Dr. Tijani is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Jefferson Health Medical Education/Jefferson Einstein Philadelphia Hospital
    Jefferson Health Medical Education/Jefferson Einstein Philadelphia HospitalResidency, Internal Medicine, 2000 - 2003
  • University of Lagos College of Medicine
    University of Lagos College of MedicineClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2027
  • PA State Medical License
    PA State Medical License 2001 - 2012
  • PA State Medical License
    PA State Medical License 2001 - 2012
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart Touch, Cerner Corporation, 2016
  • CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016
  • CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight
    Lukman Tijani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • 'Tolerability in Patients with Multiple Myeloma Treated with Daratumumab: A
    Lukman Tijani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Updated Meta-Analysis to Evaluate the Incidence of Atrial Fibrillation and
    Lukman Tijani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • 'Risk of Atrial Fibrillation with Ibrutinib in Patients with B-Cell Malignancies: 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • 'Risk of Atrial Fibrillation with Ibrutinib in Patients with B-Cell Malignancies: 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: